Agenus (AGEN) Non-Current Assets (2010 - 2026)
Agenus' (AGEN) quarterly Non-Current Assets came in at $355000.0 in Q1 2026, down 99.8% year-on-year from $177.1 million in Q1 2025, and down 9.21% quarter-over-quarter from $391000.0 in Q4 2025.
Agenus (AGEN) Non-Current Assets (2010 - 2026) Analysis & Trends
Agenus' Non-Current Assets history runs 17 years deep, the most recent figure standing at $355000.0 for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 99.8% year-over-year to $355000.0 in Q1 2026; TTM through Mar 2026 was $355000.0, a 99.95% decrease from a year earlier, with the FY2025 full-year figure at $391000.0, down 99.78% from the prior year.
- Non-Current Assets declined to $355000.0 in Q1 2026 per AGEN's latest filing, from $391000.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $212.9 million in Q2 2023 and bottomed at $355000.0 in Q1 2026.
- The 5-year median for Non-Current Assets is $180.7 million (2024), against an average of $155.0 million.
- Across the five-year window, Non-Current Assets jumped 68.17% in 2022 and tumbled 99.8% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $200.4 million in 2022, then rose by 0.53% to $201.5 million in 2023, then declined by 10.32% to $180.7 million in 2024, then tumbled by 99.78% to $391000.0 in 2025, then retreated by 9.21% to $355000.0 in 2026.
- Per Business Quant, the three latest AGEN Non-Current Assets figures stand at $355000.0 (Q1 2026), $391000.0 (Q4 2025), and $429000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 355,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,000.00 |
| Dec 31, 2025 | 391,000.00 |
| Sep 30, 2025 | 429,000.00 |
| Jun 30, 2025 | 171.88 Mn |
| Mar 31, 2025 | 177.06 Mn |
| Dec 31, 2024 | 180.70 Mn |
| Sep 30, 2024 | 188.33 Mn |
| Jun 30, 2024 | 192.41 Mn |
| Mar 31, 2024 | 196.21 Mn |
| Dec 31, 2023 | 201.50 Mn |
| Sep 30, 2023 | 209.92 Mn |
| Jun 30, 2023 | 212.86 Mn |
| Mar 31, 2023 | 207.17 Mn |
| Dec 31, 2022 | 200.43 Mn |
| Sep 30, 2022 | 177.59 Mn |
| Jun 30, 2022 | 167.24 Mn |
| Mar 31, 2022 | 150.82 Mn |
| Dec 31, 2021 | 133.98 Mn |
| Sep 30, 2021 | 129.24 Mn |
| Jun 30, 2021 | 99.45 Mn |